MRD Monitoring in Acute Lymphoblastic Leukemia
0 Visningar
administrator
06/15/23
In this segment, Raoul Tibes, MD, PhD, discusses risk stratification based on minimal residual disease monitoring in patients with acute lymphoblastic leukemia achieve remission.
Visa mer
Facebook-kommentarer
Inga kommentarer hittades